Top compounds associated with response to VPS39


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.09
mRNA UNC0321 CTRPv2 pan-cancer AAC 0.065 0.09
mRNA neratinib CTRPv2 pan-cancer AAC 0.062 0.09
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.063 0.09
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.055 0.09
mRNA GSK1059615 CTRPv2 pan-cancer AAC 0.079 0.09
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.09
mRNA lenalidomide FIMM pan-cancer AAC 0.27 0.09
mRNA lapatinib CTRPv2 pan-cancer AAC 0.062 0.09
mRNA alisertib CTRPv2 pan-cancer AAC 0.054 0.09
Download CSV